Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis Safety and Tolerability Study of LiquidAlpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fib ...
A Double Blind, Randomized, Placebo Controlled, Single Dose, Phase I Study of the Safety and Tolerability of Alpha1 Proteinase Inhibitor (Human) Inhalation Solution (CR002) in Subjects With Cystic Fibrosis A Double Blind, Randomized, Placebo Controlled, Single Dose, Phase I Study of the Safety and Tolerab ...